About ScreenPoint Medical BV
ScreenPoint Medical BV is a medical imaging AI company specializing in breast cancer detection technology. The company develops Transpara Breast AI, a comprehensive suite of AI-powered applications designed for every step of the breast imaging continuum. Born from collaboration between two leading researchers in image processing, ScreenPoint Medical maintains strong roots in applied academia while delivering clinically validated solutions to healthcare providers worldwide. Transpara Breast AI serves as a 'second pair of eyes' for radiologists, offering enhanced detection capabilities across both 2D (FFDM) and 3D (DBT) mammography. The platform is vendor-agnostic and integrates seamlessly with existing PACS systems, AI platforms, and imaging technologies. The solution addresses critical challenges facing breast imaging programs including radiologist shortages, staff burnout, rising volumes, and increasing patient expectations. The company's product suite includes Transpara Detection for cancer identification, Transpara Density for breast density assessment, and Temporal Comparison for tracking findings across multiple prior mammograms. ScreenPoint Medical's technology is backed by the most extensive clinical evidence portfolio in breast imaging AI, including 55+ peer-reviewed publications analyzing over 11 million mammograms. The company is the only breast AI provider selected for multiple randomized controlled trials, including the landmark MASAI study in Sweden, PRISM trial in the USA, and AIMS trial in Norway. Transpara is deployed across 30+ countries, serving leading healthcare institutions, screening programs, and radiology practices globally.
Mission & Story
Mission
Our focus is to continuously evolve Breast AI with innovative new products and enhanced algorithms
Founding Story
Born from the collaboration of two leading researchers in image processing, ScreenPoint's origins in applied academia required us to be relentlessly focused on pushing frontiers in AI in breast imaging
Clinical Focus
Medical conditions and clinical areas addressed by ScreenPoint Medical BV.
Who It Serves
Milestones & Awards
Recent Milestones
Selected for $16M PRISM RCT in USA (September 2025), MASAI RCT results published in The Lancet (January 2026), AITIC study published in Nature Medicine (March 2026)
Awards & Recognition
Only breast AI solution selected for multiple randomized controlled trials, most independent peer-reviewed publications in breast AI
Key Partnerships
Social & Media
.png?width=500&height=500&name=one_1%20(1).png)
.png?width=500&height=500&name=Priors%20Workflow_v1%20(1).png)
Company Details
- Headquarters
- Nijmegen, Gelderland, Netherlands
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.